SCHEMBL5205301

SCHEMBL5205301

CCOC(=O)C1=Cc2cc(Br)ccc2NCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRB2 P47870 1/20 0.39
ALDH1A1 P00352 4/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
ALOX15 P16050 1/20 0.38
MAPT P10636 5/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
JAK2 O60674 3/20 0.37
JAK3 P52333 2/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
POLB P06746 1/20 0.37
USP2 O75604 1/20 0.37
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 2/20 0.36
PLK4 O00444 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6341328 0.86 NR4A2 (0.38)
SCHEMBL7714706 0.83 TSHR (0.44) ALDH1A1JAK2GAATSHRMAPK1
SCHEMBL6349353 0.80 KDM4E (0.38) GABRA1GABRB1GABRA3GABRB2ALDH1A1
SCHEMBL3459409 0.79 GAA (0.38) MAPTGAAKDM4E
SCHEMBL3459411 0.79 GAA (0.38) MAPTGAAKDM4E
SCHEMBL3458674 0.78 NR4A2 (0.36) MAPTGAAKDM4E
SCHEMBL3458675 0.78 NR4A2 (0.36) MAPTGAAKDM4E
SCHEMBL19265538 0.77 MEN1 (0.40) GABRA1GABRB1GABRA3GABRB2ALDH1A1
SCHEMBL7248040 0.76 LMNA (0.38) GABRA1GABRB1GABRA3GABRB2ALDH1A1
SCHEMBL5209415 0.75 CCR2 (0.43) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040103-B1 ANILIDE DERIVATIVE, PRODUCTION AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2007-03-14 EP disclosed
US-6413947-B1 Anilide derivative, production and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-02 US disclosed
US-6268354-B1 Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-07-31 US disclosed
US-6172061-B1 AIDS THERAPY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-01-09 US disclosed
US-6166006-A Anilide derivative, production and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-12-26 US disclosed
EP-1039899-A2 PHARMACEUTICAL COMPOSITION FOR ANTAGONIZING CCR5 COMPRISING ANILIDE DERIVATIVE Takeda Chemical Industries, Ltd. (JP) 2000-10-04 EP disclosed
EP-1040103-A1 ANILIDE DERIVATIVE, PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2000-10-04 EP disclosed
WO-1999032100-A2 PHARMACEUTICAL COMPOSITION FOR ANTAGONIZING CCR5 COMPRISING ANILIDE DERIVATIVE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-07-01 WO disclosed
WO-1999032468-A1 ANILIDE DERIVATIVE, PRODUCTION AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-07-01 WO disclosed